Skip to content
OpenCapital
Get started

LivaNova LIVN Impairment of assets and other charges

Impairment of assets and other charges at other companies

Baxter International logo
Baxter InternationalBAX
——

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetImpairmentCharges.

The official record: LivaNova’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is LivaNova's impairment of assets and other charges?
LivaNova (LIVN) reported impairment of assets and other charges of $0 in Q4 2025.